XML 21 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Other Intangible Assets
9 Months Ended
Sep. 30, 2016
Goodwill And Other Intangible Assets Disclosure [Abstract]  
Goodwill And Other Intangible Assets Disclosure [Text Block]

5. Goodwill and Other Intangible Assets

Intangible assets consist of the following:

Weighted
Average
September 30, 2016December 31, 2015Life (a)
(in thousands)
Amortizable intangible assets:GrossAccumulated AmortizationGrossAccumulated Amortization
Existing technology$15,687$(11,962)$16,022$(11,686)7.1Years
Trade names7,623(3,440)7,636(3,076)8.2Years
Distribution agreements/customer relationships23,653(12,800)23,676(11,849)9.1Years
Patents216(116)245(96)2.4Years
Total amortizable intangible assets47,179$(28,318)47,579$(26,707)
Indefinite-lived intangible assets:
Goodwill39,62440,357
Other indefinite-lived intangible assets1,2271,223
Total goodwill and other indefinite-lived intangible assets40,85141,580
Total intangible assets, gross$88,030$89,159
(a) Weighted average life as of September 30, 2016.

The change in the carrying amount of goodwill for the nine months ended September 30, 2016 is as follows:

(in thousands)
Balance at December 31, 2015$40,357
Adjustment to purchase price allocation of prior year acquisition50
Effect of change in currency translation(783)
Balance at September 30, 2016$39,624

Impairment of intangible assets

During the third quarter of 2016, the Company initiated plans to sell the operations of its AHN Biotechnologie GmbH subsidiary (“AHN”), a manufacturer of liquid handling products, located in Nordhausen, Germany. The Company assessed the held for sale accounting guidance, pursuant to ASC 360-10, and concluded that it had not met all the criteria for AHN’s assets and liabilities to be classified as held for sale as of September 30, 2016. As such, AHN’s assets and liabilities continue to be presented as held and used, and the results of its operations included within continuing operations as of, and for the three and nine months ended September 30, 2016, respectively.

As a result of the Company initiating plans to sell the operations of AHN, the Company evaluated the long-lived assets for impairment, pursuant to ASC 360-10. Based on the impairment analysis, the carrying amount of the long-lived assets exceeded the fair value of the long-lived assets as determined using the probability weighted present value of future cash flows. As a result, the Company recognized an impairment charge of $0.7 million for the three and nine months ended September 30, 2016 as part of operating expenses within its statements of operations. Of the overall charge, approximately $0.1 million was allocated to its intangible assets (trade name and customer relationships), while the remainder of the charge was allocated to its property, plant and equipment (machinery and equipment).

As also noted in footnote 18, on October 26, 2016, the Company sold AHN for $1.7 million in cash proceeds.

Amortization of intangible assets

Intangible asset amortization expense was $0.7 million for both the three months ended September 30, 2016 and 2015. Intangible asset amortization expense was $2.1 million for both the nine months ended September 30, 2016 and 2015. Amortization expense of existing amortizable intangible assets is currently estimated to be $2.6 million for the year ending December 31, 2016, $2.5 million for the year ending December 31, 2017, $2.3 million for the year ending December 31, 2018, $2.2 million for the year ending December 31, 2019 and $2.1 million for the year ending December 31, 2020.